Inhibitors of FAM122C function by interfering with the signaling pathways and enzymatic activities that regulate this protein's activity within cells. For instance, specific inhibitors target kinases within the MAPK/ERK pathway, resulting in a reduction of phosphorylation events critical to the functional regulation of FAM122C. By attenuating kinase activity, these inhibitors can significantly diminish the phosphorylation-dependent modulation of FAM122C, thereby decreasing its activity. Similarly, other inhibitors obstruct the PI3K/AKT signaling cascade, which is integral to the regulation of numerous proteins including FAM122C. The inhibition of this pathway can lead to a reduction in the downstream signaling events that are essential for the optimal functioning of FAM122C.
Further interrupting FAM122C's role in cellular processes, additional inhibitors target mTOR signaling, EGFR tyrosine kinase activity, and various MAPKs such as p38 and JNK. These inhibitors collectively contribute to a comprehensive suppression of FAM122C activity by preventing the activation of pathways that modulate its function. Inhibition of mTOR, for example, may affect FAM122C by altering the cell's response to growth signals, which could be an indirect regulatory mechanism for this protein. Inhibitors that target the EGFR tyrosine kinase disrupt upstream signaling, leading to reduced activity of downstream proteins, possibly including FAM122C.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor that impairs the MAPK/ERK pathway, leading to reduced phosphorylation activity which FAM122C relies on for its regulatory functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that disrupts the PI3K/AKT signaling pathway, decreasing the activity of downstream proteins including FAM122C. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that attenuates the p38-mediated signaling cascade, potentially diminishing FAM122C activity which is modulated by this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, leading to interruption of the JNK signaling pathway which is essential for the full activity of FAM122C. | ||||||
WZ4003 | 1214265-58-3 | sc-473979 | 5 mg | $300.00 | ||
A NUAK family kinase inhibitor, directly impeding a kinase that could phosphorylate and thus regulate FAM122C function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor which disrupts downstream signaling, potentially affecting the regulatory functions of FAM122C within the cell. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
An EGFR tyrosine kinase inhibitor, leading to reduced signaling through pathways that involve FAM122C. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A selective inhibitor of MEK1/2, resulting in blockade of the MAPK/ERK pathway on which FAM122C may act. | ||||||
BIX 02189 | 1094614-85-3 | sc-364436 sc-364436A | 5 mg 10 mg | $220.00 $378.00 | 5 | |
An inhibitor of MEK5, which could prevent activation of ERK5 and related pathways, affecting FAM122C activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor that impedes the PI3K/AKT signaling, leading to decreased activity of FAM122C which is influenced by this pathway. |